Key facts
- This page summarizes Kimberly Kraig Thompson's Form 4 filing for Kraig Biocraft Laboratories, Inc (KBLB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Apr 2025, 16:44.
Kimberly Kraig Thompson - 31 Mar 2025 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)
- Reporting relationship
- Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- KBLB
- Reported as of
- 31 Mar 2025
- Net transaction value
- +$2,492
- SEC form
- 4
- Accepted by SEC
- 10 Apr 2025, 16:44:55 UTC
- Prior SEC filing
- 21 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- Kim Thompson, CEO
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kimberly Kraig Thompson filed Form 4 for Kraig Biocraft Laboratories, Inc (KBLB) on 10 Apr 2025.
Change
- Previous filing in this sequence was filed on 21 Jul 2022.
- Current net transaction value: +$2,492.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KBLB
transaction
Common Stock
Will/Inheritance
- Transaction value
- $2,492
- Shares
- +27,500
- Change %
- +0.01%
- Price
- $0.0906
- Shares after
- 201,677,922
- Date
- 31 Mar 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.